Narcís Saubí Roca I am a Biochemist, and I am in the Microbiology department, in the Respiratory Virus Unit, working on the isolation in cell cultures and phenotypic characterization of different respiratory viruses (Influenza, RSV, hMPV, enterovirus). I am also collaborating with other HUVH and VHIR research groups that require the growth of viruses in cultures. Previously, I was working on the development of preventive vaccines against HIV (one based on Bacillus Calmette-Guerin (BCG), and the other based on Virus-Like particles -VLP- of the human papillomavirus) and SARS - CoV-2. Institutions of which they are part Senior researcher Microbiology Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Narcís Saubí Roca LinkedIn Twitter Orcid Email Institutions of which they are part Senior researcher Microbiology Vall Hebron Institut de Recerca I am a Biochemist, and I am in the Microbiology department, in the Respiratory Virus Unit, working on the isolation in cell cultures and phenotypic characterization of different respiratory viruses (Influenza, RSV, hMPV, enterovirus). I am also collaborating with other HUVH and VHIR research groups that require the growth of viruses in cultures. Previously, I was working on the development of preventive vaccines against HIV (one based on Bacillus Calmette-Guerin (BCG), and the other based on Virus-Like particles -VLP- of the human papillomavirus) and SARS - CoV-2.
In December 2021, I joined the Respiratory Virus Unit at the Microbiology Department, with Dr. Andrés Antón, to perform isolation and phenotypic characterization of respiratory viruses (Influenza, RSV, hMPV, enterovirus). It is also among my roles to support other VHIR and HUVH groups. Previously, I had been working on the development of preventive vaccines against HIV and SARS-CoV-2. The vaccines were based on the use of Bacillus Calmette-Guérin (BCG) as a vaccine vector, and on the use of chimeric VLPs (Virus Like Particles) of the Human Papilloma Virus that expressed HIV or SARS-CoV-2 epitopes. I started this research in 2005, at the Infectious Diseases and HIV Group of the Hospital Clínic de Barcelona, with Dr. Joan Joseph. This was the subject of my doctoral thesis. In 2019, the entire research group moved to the Microbiology Department of Vall d’Hebron University Hospital. I started my career in vaccine research and development at Laboratorios Hipra, S.A., where I worked for 13 years on vaccines against avian, porcine and bovine virus research, development and manufacture.
Projects Synthetic erythrocytes for the global control of influenza viruses: activities for technology transfer. IP: Eva Baldrich Rubio Collaborators: Xana Garcia Fernandez, Edgar Fuentes Fuentes, Maria Urpí Castany, Cristina Andrés Vergés, Narcís Saubí Roca Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 84000 Reference: 2025 INNOV 00007 Duration: 17/11/2025 - 16/06/2027 Eritròcits sintètics pel control global de les infeccions per virus influenza: escalat de la producció i validació de camp IP: Eva Baldrich Rubio Collaborators: Andres Antón Pagarolas, Tomàs Pumarola Suñé, Maria Urpí Castany, Cristina Andrés Vergés, Narcís Saubí Roca Funding agency: Generalitat de Catalunya - Departament de Salut Funding: 99946 Reference: SLT036/24/000017 Duration: 21/12/2024 - 30/06/2026 Sintrocito: eritròcits sintètics pel contgrol global de la grip IP: Eva Baldrich Rubio Collaborators: Andres Antón Pagarolas, Xana Garcia Fernandez, Maria Urpí Castany, Cristina Andrés Vergés, Narcís Saubí Roca Funding agency: Fundació Institut de Recerca HUVH Funding: 10000 Reference: VHIR-FIT-2024-001 Duration: 13/12/2024 - 12/12/2025 Disección y promoción de inmunidad adaptativa específica frente al poliomavirus (BKV) para prevenir la infección viral tras el trasplante renal (proyecto BK-VAX). IP: Oriol Bestard Matamoros Collaborators: Disección y promoción de inmunidad adaptativa específica frente al poliomavirus (BKV) para prevenir la infección viral tras el t, Joana Sellarés Roig, Emma Pardo De los Santos, Elena Isabel Crespo Gimeno, Laura Donadeu Casassas, Narcís Saubí Roca Funding agency: Instituto de Salud Carlos III Funding: 174240 Reference: PI22/01019 Duration: 01/01/2023 - 31/12/2026 Pagination Current page 1 Page 2 Next page › Last page »
